ArticleAmerican journal of clinical oncology2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.
Roger B Cohen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
109 papers cite itlatest 60 shown
this paperpooled ittrialcites it